English | Spanish
ecancer
Supporting oncology professionals through education
Login Register

The content on this site is intended for healthcare professionals only

  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

News

  • Latest news
  • Sign up for news alerts
  • Submit your news

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Journal information

  • Journal home
  • Charges
  • Editorial board
  • Founding editors
  • Editor-in-chief
  • Contact us

Author information

  • Submit article
  • Author guidelines
  • Editorial policies
  • Copyright information
  • Why publish with us

Reviewer information

  • Reviewer guidelines

Memberships

Open Access Scholarly Publishers Association Crossref Healthcare Information For All Commitee On Publication Ethics

Videos

  • Recent videos
  • Sign up

Explore

  • Bone
  • Brain & nervous system
  • Breast
  • Colorectal & gastro
  • Haematology oncology
  • Head & neck
  • Hepatobiliary pancreatic
  • Lung & pleura
  • Melanoma & skin
  • Neuroendocrine
  • Ovary & gynaecology
  • Paediatric
  • Prostate & urology
  • Sarcomas

Conferences

  • Latest conferences
  • Sign up for latest coverage
  • Submit your event

About ecancer

  • About ecancer
  • Our founders
  • Funding statement
  • Contact us
  • Home
  • News
  • Journal
  • Video
  • elearning
  • Events
  • Conferences
  • About us
Breast Prostate & urology Lung & pleura Colorectal & gastro Melanoma & skin Head & neck Ovary & gynaecology
+ -
Bone Brain & nervous system Haematology oncology Hepatobiliary pancreatic Paediatric Neuroendocrine Sarcomas

ecancer and the City Cancer Challenge have formed an educational collaboration. Learners who are part of the City Cancer Challenge's project can access additional education provided by them.

Please login or register. Then you can use this button to confirm you are part of this project.
Register for free Already have an account? Login
Videos [3413]
News [7779]
Articles [63]
Editorials [9]
Conferences [208]
elearning [49]
A microRNA driver of B-cell leukaemia
Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy
A microRNA driver of B-cell leukaemia ( Prof Luigi Naldini - Universita Vita-Salute San Raffaele, Milan, Italy )
11 Jun 2016
The latest in CLL from EHA 2016
Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam
The latest in CLL from EHA 2016 ( Prof Peter Hillmen, Prof Paolo Ghia, Dr Chris Fox and Dr Constantine Tam )
11 Jun 2016
Safety and efficacy of imatinib generics
Prof Tomasz Sacha - Jagiellonian University, Krakow, Poland
Safety and efficacy of imatinib generics ( Prof Tomasz Sacha - Jagiellonian University, Krakow, Poland )
11 Jun 2016
Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo
Dr Amir Fathi, Massachusetts General Hospital, Boston, USA
Older patients with AML benefit greatly from SGN-CD33 and HMA therapy combo ( Dr Amir Fathi, Massachusetts General Hospital, Boston, USA )
11 Jun 2016
Meta-analysis of overall survival in multiple myeloma treated with lenalidomide
Dr Philip McCarthy - Roswell Park Cancer Institute, New York, USA
Meta-analysis of overall survival in multiple myeloma treated with lenalidomide ( Dr Philip McCarthy - Roswell Park Cancer Institute, New York, USA )
11 Jun 2016
Clinical characteristics and prognostic factors of plasmablastic lymphoma...
Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France
Clinical characteristics and prognostic factors of plasmablastic lymphoma patients ( Dr Emmanuelle Tchernonog - CHRU Montpellier, Montpellier, France )
11 Jun 2016
Blinatumomab improves survival of relapsed B-cell leukaemia
Prof Max Topp - University of Würzburg, Würzburg, Germany
Blinatumomab improves survival of relapsed B-cell leukaemia ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
11 Jun 2016
Decoding the risk of thromboembolic events in lymphoma patients
Prof Darko Antic - Clinic For Hematology, Clinical Center Serbia, Belgrade...
Decoding the risk of thromboembolic events in lymphoma patients ( Prof Darko Antic - Clinic For Hematology, Clinical Center Serbia, Belgrade, Serbia )
11 Jun 2016
SGN-CD33A combined with HMA therapy produces high remission rates among older...
Dr Amir Fathi - Massachusetts General Hospital, Boston, USA
SGN-CD33A combined with HMA therapy produces high remission rates among older patients with AML ( Dr Amir Fathi - Massachusetts General Hospital, Boston, USA )
11 Jun 2016
Killer antibodies against AML
Dr Mette Hazenberg - AMC, Amsterdam, The Netherlands
Killer antibodies against AML ( Dr Mette Hazenberg - AMC, Amsterdam, The Netherlands )
11 Jun 2016
SL401 in patients with rare neoplasm
Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center...
SL401 in patients with rare neoplasm ( Prof Naveen Pemmaraju - The University of Texas MD Anderson Cancer Center, Houston, United States )
10 Jun 2016
Blinatumomab improves survival in ALL patients
Prof Max Topp - University of Würzburg, Würzburg, Germany
Blinatumomab improves survival in ALL patients ( Prof Max Topp - University of Würzburg, Würzburg, Germany )
10 Jun 2016
<1...160161162163164...285>

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation

  • Contact
  • Projects
  • Cookie Policy
  • Terms of Use
  • Desktop Site
  • Privacy Policy
© 2025 ecancer, all rights reserved
UK registered charity number: 1176307
Back to Top